{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## CORD-19 literature mining code for system implementation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "## Import libraries\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib as plt\n",
    "from sentence_transformers import SentenceTransformer, util\n",
    "from transformers import AutoTokenizer, AutoModelForQuestionAnswering\n",
    "import torch\n",
    "import csv\n",
    "import os\n",
    "import json\n",
    "from nltk import tokenize\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "import random\n",
    "import pickle\n",
    "from vaderSentiment.vaderSentiment import SentimentIntensityAnalyzer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "## Load models\n",
    "device = torch.device('cpu')\n",
    "# sbert embedder\n",
    "embedder = SentenceTransformer('msmarco-distilbert-base-v4').to(device)\n",
    "# QA model\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"gerardozq/biobert_v1.1_pubmed-finetuned-squad\")\n",
    "model = AutoModelForQuestionAnswering.from_pretrained(\"gerardozq/biobert_v1.1_pubmed-finetuned-squad\").to(device)\n",
    "\n",
    "\n",
    "## TFIDF processing\n",
    "\n",
    "filename = 'tfidf_doc'\n",
    "infile = open(filename,'rb')\n",
    "tfidf_doc = pickle.load(infile)\n",
    "infile.close()\n",
    "\n",
    "doc_list = tfidf_doc['doc_list']\n",
    "doc_list_word = tfidf_doc['doc_list_word']\n",
    "\n",
    "\n",
    "\n",
    "def dummy_fun(doc):\n",
    "    return doc\n",
    "\n",
    "tfidf = TfidfVectorizer(\n",
    "    analyzer='word',\n",
    "    tokenizer=dummy_fun,\n",
    "    preprocessor=dummy_fun,\n",
    "    token_pattern=None)  \n",
    "\n",
    "tfidf_matrix = tfidf.fit_transform(doc_list)\n",
    "\n",
    "## SBERT processing\n",
    "\n",
    "filename = 'sbert_doc'\n",
    "infile = open(filename,'rb')\n",
    "sbert_doc = pickle.load(infile)\n",
    "infile.close()\n",
    "\n",
    "paracorp = sbert_doc['paracorp']\n",
    "para_doc = sbert_doc['para_doc']\n",
    "\n",
    "                \n",
    "filename = 'emb_corpus300'\n",
    "infile = open(filename,'rb')\n",
    "corpus_embeddings1 = pickle.load(infile)\n",
    "infile.close()\n",
    "\n",
    "corpus = paracorp\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def cord19mining(symptomInput = ['pain']):\n",
    "\n",
    "    symptomlist = []\n",
    "    rejectlist = ['covid-19', 'blood test','computerised tomogram','sars-cov-2 test positive',\n",
    "                  'cerebrovascular accident','electrocardiogram','echocardiogram','troponin increased',\n",
    "                 'arthralgia','myalgia','hyperhidrosis','paraesthesia','hypoaesthesia','feeling abnormal']\n",
    "    for symptom in symptomInput:\n",
    "        if symptom == 'dyspnoea':\n",
    "            symptom1 = 'dyspnea'\n",
    "        elif symptom == 'pyrexia':\n",
    "            symptom1 = 'fever'\n",
    "        elif symptom == 'injection site erythema':\n",
    "            symptom1 = 'erythema'\n",
    "        elif symptom == 'myalgia':\n",
    "            symptom1 = 'myalgias'\n",
    "        elif symptom == 'lymphadenopathy':\n",
    "            symptom1 = 'lymph nodes'\n",
    "        elif symptom in rejectlist:\n",
    "            symptom1 = 'pain'\n",
    "        else:\n",
    "            symptom1 = symptom\n",
    "        \n",
    "        if symptom1 not in symptomlist:\n",
    "            symptomlist.append(symptom1)\n",
    "        \n",
    "    \n",
    "    output = {}\n",
    "    i = 1\n",
    "    \n",
    "    resultlist_value = torch.empty((0))\n",
    "    resultlist_indices = torch.empty((0))\n",
    "    query_symp = []\n",
    "\n",
    "    for symp in symptomlist:\n",
    "        # Auto-query generation\n",
    "        query = 'is ' + str(symp) + ' caused by vaccine a severe adverse effect'\n",
    "        #queries = ['is fever caused by pfizer vaccine a severe adverse effect']\n",
    "        # tfidf score\n",
    "        query_token = tokenizer(query)\n",
    "        query_vec = tfidf.transform([query_token['input_ids'][1:len(query_token['input_ids'])-1]])\n",
    "        cosine_sim = cosine_similarity(tfidf_matrix, query_vec)\n",
    "        tfidf_score = torch.FloatTensor(np.transpose(cosine_sim)[0])\n",
    "\n",
    "        # sbert score\n",
    "        top_k = min(5, len(corpus))\n",
    "\n",
    "        query_embedding = embedder.encode(query, convert_to_tensor=True)\n",
    "        \n",
    "        k_coeff = 0.7\n",
    "        \n",
    "        # Linear combination of tfidf and sbert scores to find the highest 5 scores\n",
    "        cos_scores = util.pytorch_cos_sim(query_embedding, corpus_embeddings1)[0]\n",
    "        combined_scores = k_coeff*cos_scores + (1-k_coeff)*tfidf_score\n",
    "        top_results = torch.topk(combined_scores, k=top_k)\n",
    "        resultlist_value = torch.cat((resultlist_value,top_results[0]))\n",
    "        resultlist_indices = torch.cat((resultlist_indices,top_results[1]))\n",
    "        query_symp.extend([symp for i in range(5)])\n",
    "    \n",
    "    top_results_list = torch.topk(resultlist_value, k=top_k)\n",
    "    symp_idx = top_results_list[1].tolist()\n",
    "    query_symp = [query_symp[i] for i in symp_idx]\n",
    "    qi = 0\n",
    "\n",
    "    \n",
    "    for idx in resultlist_indices[top_results_list[1]].int():\n",
    "        # QA search\n",
    "        question = 'is ' + query_symp[qi] + ' caused by vaccine a severe adverse effect'\n",
    "        text = corpus[idx]\n",
    "        inputs = tokenizer(question, text, add_special_tokens=True, return_tensors=\"pt\")\n",
    "        input_ids = inputs[\"input_ids\"].tolist()[0]\n",
    "        outputs = model(**inputs)\n",
    "        answer_start_scores = outputs.start_logits\n",
    "        answer_end_scores = outputs.end_logits\n",
    "        # Get the most likely beginning of answer with the argmax of the score\n",
    "        answer_start = torch.argmax(answer_start_scores)\n",
    "        # Get the most likely end of answer with the argmax of the score\n",
    "        answer_end = torch.argmax(answer_end_scores) + 1\n",
    "        answer = tokenizer.convert_tokens_to_string(tokenizer.convert_ids_to_tokens(input_ids[answer_start:answer_end]))\n",
    "        \n",
    "        # Sentiment analyzer\n",
    "        analyzer = SentimentIntensityAnalyzer()\n",
    "        sentence = answer \n",
    "        vs = analyzer.polarity_scores(sentence)\n",
    "        \n",
    "        output[i] = {}\n",
    "        output[i]['text'] =  para_doc[idx.item()]['text']\n",
    "        output[i]['title'] =  para_doc[idx.item()]['title']\n",
    "        output[i]['authors'] =  para_doc[idx.item()]['authors']\n",
    "        output[i]['publish_time'] = para_doc[idx.item()]['publish_time'].strftime('%m/%d/%Y')     \n",
    "        output[i]['journal'] =  para_doc[idx.item()]['journal']\n",
    "        output[i]['sentiment'] =  vs\n",
    "        i = i + 1\n",
    "        qi = qi + 1\n",
    "        \n",
    "    return output\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{1: {'text': 'Vaccines activate the immune system, which will commonly result in minor side effects, including mild fever and local inflammatory reactions at the site of the injection. This may include redness, swelling, pain, and warmth at the injection sites [1] . These reactions are not a contraindication to receiving the same vaccine in the future, as they do not pose a risk for future allergic reactions to the vaccine. Non-allergic reactions to vaccines also include anxiety-related adverse events that can mimic allergic reactions, and may include breath-holding, hyperventilation, and vasovagal syncope (fainting) (see Table 1 in the Canadian Immunization Guide: Anaphylaxis and other Acute Reactions following Vaccination) [2] .',\n",
       "  'title': 'COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)',\n",
       "  'authors': 'Vander Leek, Timothy K.; Chan, Edmond S.; Connors, Lori; Derfalvi, Beata; Ellis, Anne K.; Upton, Julia E. M.; Abrams, Elissa M.',\n",
       "  'publish_time': '03/15/2021',\n",
       "  'journal': 'Allergy Asthma Clin Immunol',\n",
       "  'sentiment': {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}},\n",
       " 2: {'text': 'In this phase 1/2 clinical trial among healthy adults, the SARS-CoV-2 inactivated vaccine was safe and well-tolerated in all age and dose groups, and 15¢1% of participants experienced adverse reactions. The most common injection-site adverse reaction was injection-site pain, and the most common systemic adverse reaction was fever, which were mostly mild-to-moderate and self-limiting. No serious adverse reactions related to the vaccine occurred. The inactivated vaccine could effectively elicit humoral responses, and the GMT of neutralizing antibody titres on days 28 and 90 after the third injection ranged from 149 to 238 and 87 to 129, respectively among participants receiving three doses of vaccines. In general, the antibody response was weaker in 5 mg days 0 and 14 group and 10 mg day 0 group. Given that large-scale production of the inactivated vaccine would be achievable and the vaccine could be stored at 2À8°C, the inactivated vaccine could be an optimal option for many developing countries and regions where cold storage and distribution capacity was relatively poor.',\n",
       "  'title': 'Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial',\n",
       "  'authors': 'Guo, Wanshen; Duan, Kai; Zhang, Yuntao; Yuan, Zhiming; Zhang, Yan-Bo; Wang, Zejun; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Wei; Yang, Yunkai; Chen, Wei; Gao, Xiaoxiao; You, Wangyang; Wang, Xue-Wei; Shi, Zhengli; Wang, Yanxia; Yang, Xu-Qin; Zhang, Lianghao; Huang, Lili; Wang, Qian; Lu, Jia; Yang, Yong-Li; Guo, Jing; Zhou, Wei; Wan, Xin; Wu, Cong; Wang, Wenhui; Du, Jianhui; Nian, Xuanxuan; Li, Xing-Hang; Huang, Shihe; Shen, Shuo; Xia, Shengli; Pan, An; Yang, Xiaoming',\n",
       "  'publish_time': '07/07/2021',\n",
       "  'journal': 'EClinicalMedicine',\n",
       "  'sentiment': {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}},\n",
       " 3: {'text': \"Overall, the most frequent adverse effects reported after the administration of the three vaccines considered in this review consisted of local reactions at the injection site (sore arm and erythema) followed by non-specific systemic effects (myalgia, chills, fatigue, headache, and fever). These adverse reactions are considered as the result of the immune system's reaction that occurs soon after vaccination (also referred to as reactogenicity) and resolves shortly [35] . Given the scale-up of mass vaccination campaigns across the world, severe adverse events may occur and will likely generate concerns among patients and requests for evaluation.\",\n",
       "  'title': 'Safety of COVID-19 vaccines administered in the EU: Should we be concerned?',\n",
       "  'authors': 'Hernández, Antonio F.; Calina, Daniela; Poulas, Konstantinos; Docea, Anca Oana; Tsatsakis, Aristidis M.',\n",
       "  'publish_time': '04/20/2021',\n",
       "  'journal': 'Toxicol Rep',\n",
       "  'sentiment': {'neg': 0.267, 'neu': 0.733, 'pos': 0.0, 'compound': -0.6249}},\n",
       " 4: {'text': 'Severe allergic reactions due to anaphylaxis represent a very rare side effect associated with most vaccines, including mRNA vaccines. For this reason, it has been recommended that subjects with a previous history of severe allergic reactions to any vaccine ingredient should not receive it [36] . This safety concern is currently followed-up via routine pharmacovigilance.',\n",
       "  'title': 'Safety of COVID-19 vaccines administered in the EU: Should we be concerned?',\n",
       "  'authors': 'Hernández, Antonio F.; Calina, Daniela; Poulas, Konstantinos; Docea, Anca Oana; Tsatsakis, Aristidis M.',\n",
       "  'publish_time': '04/20/2021',\n",
       "  'journal': 'Toxicol Rep',\n",
       "  'sentiment': {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}},\n",
       " 5: {'text': 'In the population analysed, only one serious adverse event (0.05%) was reported in an approximately 30-year-old female subject, who was immediately hospitalised after the second dose of vaccine due to symptoms similar to anaphylaxis (skin rash and glottal oedema). This serious adverse reaction was completely resolved within 24 hours.',\n",
       "  'title': 'Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021',\n",
       "  'authors': 'Ossato, Andrea; Tessari, Roberto; Trabucchi, Carlotta; Zuppini, Teresa; Realdon, Nicola; Marchesini, Francesca',\n",
       "  'publish_time': '07/26/2021',\n",
       "  'journal': 'Eur J Hosp Pharm',\n",
       "  'sentiment': {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}}}"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cord19mining(symptomInput = ['pyrexia', 'injection site warmth'])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
